Brief: Neovacs Announces Capital Rise Of 2 Million Euros
July 5 (Reuters) - NEOVACS SA ALNEV.PA :
* ANNOUNCED ON SUNDAY A CAPITAL RISE OF EUR 2 MILLION
* CAPITAL INCREASE THROUGH THE DRAWDOWN OF 2 TRANCHES OF
CONVERTIBLE BONDS (OCEANE-BSA), WITH A NOMINAL VALUE OF 1,000
000 €
* NET PROCEEDS OF THIS OPERATION WILL BE USED, FOR 50%, TO
FINANCE
THE KINOÏDE® RESEARCH PROGRAM ON ALLERGIES AND, FOR 50%, TO
STRENGTHEN INVESTMENT CAPACITIES IN PROMISING PROJECTS
Source text for Eikon: urn:newsml:reuters.com:*:nACT70012
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants